improving treatment and sharing decision making in pancreatic cancer
Post on 31-Dec-2015
62 Views
Preview:
DESCRIPTION
TRANSCRIPT
Improving Treatment and Sharing Decision Making in
Pancreatic Cancer
Activity Goals
Pancreatic Cancer: Incidence/Survival
Cellular Classification of Pancreatic Cancer
Biology of Pancreatic Cancer
Diagnosis and Staging
Endoscopic Ultrasound-guided FNA of a Pancreatic Mass Lesion
Sites of Pancreatic Neoplasia Not Seen by Triple-phase CT
To Determine When Obstructive Jaundice Is Associated With Pancreatic Cancer
Resectable Tumor
Management of Obstructive Jaundice
Placement of Biliary Stent
Neoadjuvant Trials on Borderline Resectable Pancreatic Cancer
CA19-9: Its Role in Pancreatic Cancer
Role of Laparoscopy in Pancreatic Cancer
Role of Neoadjuvant Therapy (NAT)
NAT for Resectable and Borderline-resectable Pancreatic Cancer
Multidisciplinary and Experienced Approach
An Overview of Gemcitabine-based Therapies
Agents for Metastatic Pancreatic Cancer
ACCORD Study: FOLFIRINOX vs Gemcitabine
ACCORD Study: Baseline Characteristics
ACCORD Study: Safety
Improved OS With FOLFIRINOX
ACCORD Study: Efficacy
Nab-Paclitaxel vs Gemcitabine: Study Design
Efficacy of Nab-Paclitaxel vs Gemcitabine
Palliative Care
Paucity of Enrollment in Clinical Trials
Clinical Trials Open in the US in 2011 and 2012 by Disease
Stage
Educate Patients Early About Enrollment in Clinical Trials
Patient Example
Patient Education
Phase 2 Study of MM-398
Combinations in Clinical Trials
Abbreviations
Abbreviations (cont)
Abbreviations (cont)
References
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)
top related